Condition
Endophthalmitis Postoperative
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (2)
P 4 (1)
Trial Status
Unknown2
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07717944Not ApplicableCompleted
Phacovitrectomy Versus Pars Plana Vitrectomy Alone for Post-Intravitreal Injection Endophthalmitis
NCT03634852Phase 4CompletedPrimary
A Two Chemoprophylaxis Approaches After Phacoemulsification Surgery
NCT04212429Phase 1UnknownPrimary
The Clinical Safety of Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%
NCT04212078Phase 1UnknownPrimary
Intracameral Levofloxacin (0.5%) vs Intracameral Cefuroxime
Showing all 4 trials